More recently, observational studies have hinted at how DMARDs and tumor necrosis factor–inhibiting biological therapies could reduce the incidence of dementia,42 but subsequent interventional studies have been disappointing.43 Furthermore, research on whether therapies designed to treat inflammatory and autoimmune diseases have the potential to slow down cognitive decline in dementia is lacking. The gene discussed is TNF; the disease is autoimmune disease.